ReSolution Equine IgG-Rhodococcus Equi Antibody Equine Origin

For veterinary use only

Volume: 1000 ml

ReSolution IgG is as intravenous treatment for failure of passive transfer and as an aid in the control of foal pneumonia caused by Rhodococcus equi by reducing disease severity. The average foal should receive one liter of Equine IgG - Rhodococcus Equi Antibody within the first three days of life. Dose at a rate of 20 ml/kg of body weight (approximately 10 ml/pound). This product is for use in neonatal foals.

ReSolution IgG is collected in a sterile closed system and may contain plasma from several donors. ReSolution IgG is collected from healthy horses testing negative for the antibodies against Aa, Ca, and Qa red cell antigens, as well as, EIA and EVA. Sodium citrate is used as an anticoagulant as part of the manufacturing process. ReSolution IgG does not contain preservatives.

Use: ReSolution IgG is stored frozen until used (store below 23°F). To use, warm to body temperature (90-101°F) by submerging in a warm water bath (110-115°F) for 10 minutes. To circulate for faster thawing, squeeze bag periodically. Do not mix with other products. Do not microwave this product! In case of human exposure, contact a physician.

Administer using an IV administration kit with filter. Caution should be observed however, as occasionally intravenous infusion may result in shaking, sweating, or hyperventilation. If this occurs, discontinue use for 5-10 minutes. Then resume at a slower rate of infusion. If adverse reactions persist, discontinue use.

Caution: Please administer plasma and antibody products prior to the use of milk replacer. This is a matter of product compatibility, not product quality. There is always the possibility, while rare, of transmission of viral disease in any blood product. This product has not been processed by heating or treating with ionizing radiation and therefore may be capable of spreading disease.

A condition referred to as equine serum hepatitis, or Theiler’s Disease, has been linked to the usage of products containing equine serum or plasma. Current research has implicated Equine Parvovirus (EqPV) as a potential causative agent for equine serum hepatitis, or Theiler’s Disease.

Mg Biologics

(877) 769-2340

2366 270th St. Ames, IA 50014

US Veterinary License Number 614

Product Code Number 3900.00

V. 1-2020

CPN: 1260014.1